Revance Therapeutics logo
Revance Therapeutics RVNC
$ 3.86 1.45%

Quarterly report 2024-Q3
added 11-07-2024

report update icon

Revance Therapeutics PEG Ratio 2011-2024 | RVNC

Annual PEG Ratio Revance Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
3.93 -2.52 -0.39 -0.489 -0.888 -2.56 0.326 1.14 -1.01 0.516 - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
3.93 -2.56 -0.195